“When you take a really long time to get a bulletin out to tell people about these issues, a lot of time, people have already consumed the product.”
By Christopher Osher and Evan Wyloge, The Denver Gazette
This story was originally published by ProPublica.
In March 2022, Colorado public health officials started getting startling reports of liver damage tied to a new marijuana-based sleep aid that had quickly become a top seller in the state.
But it wasn’t until June 2023, nearly 15 months later, that the state’s Marijuana Enforcement Division would warn consumers that the danger had become so serious that the manufacturer had halted production of the sleep pills, called 1906 Midnight Drops, after more reports of “acute liver injury.”
The delay highlights a slew of weaknesses in the system for protecting consumers from hazardous products in the nation’s first regulated recreational marijuana market.
The health complaints had prompted the division to investigate, but the agency decided it didn’t have the power to pull the drops from the stores in this situation. If the agency had dug deeper, it might have found what the state attorney general’s office later discovered: The manufacturer, Sima Sciences, began receiving complaints of
Read full article on Marijuana Moment
